Page last updated: 2024-11-05

1-octene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-Octene is an alpha olefin with the formula CH3(CH2)5CH=CH2. It is a colorless liquid with a mild odor. It is primarily used as a comonomer in the production of linear low-density polyethylene (LLDPE) and other polymers. 1-Octene can be synthesized through various methods, including the dimerization of butene, the oligomerization of ethylene, and the metathesis of olefins. It is also a valuable intermediate in the synthesis of other chemicals, including surfactants, plasticizers, and lubricants. 1-Octene is studied for its potential applications in various fields, including the development of new materials, the improvement of existing polymers, and the creation of sustainable and biodegradable products.'

1-octene: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1-octene : An octene with an unsaturation C-1. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8125
CHEMBL ID1376677
CHEBI ID46708
MeSH IDM0113869

Synonyms (62)

Synonym
AKOS009031490
.alpha.-octylene
.alpha.-octene
n-1-octene
nsc-8457
nsc8457
caprylene
octene-1
1-octene
111-66-0
oct-1-ene
inchi=1/c8h16/c1-3-5-7-8-6-4-2/h3h,1,4-8h2,2h
NCGC00091537-01
octylene
hsdb 1084
1-octylene
ai3-28403
nsc 8457
einecs 203-893-7
1-octene, 98%
1-octene, analytical standard
CHEBI:46708 ,
1-caprylene
alpha-octene
1-c8h16
alpha-octylene
octene
O0041
O0251
NCGC00091537-02
NCGC00258206-01
dtxsid6025804 ,
tox21_200652
cas-111-66-0
dtxcid705804
68527-00-4
ec 203-893-7
e5vk21b9rc ,
unii-e5vk21b9rc
FT-0608183
STL372709
alkenes, c8-9 .alpha.-
BBL027759
caprylene [mi]
octene, 1-
octene [inci]
1-octene [fhfi]
1-octene [hsdb]
1-n-octene
neodene 8
shop c8
CHEMBL1376677
mfcd00009548
J-002614
1-octene, purum, >=97.0% (gc)
1-octene, 97%
c8-9 alpha-alkenes
VS-08589
Q161664
D91846
26746-84-9
EN300-19738
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
octene
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (10)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency104.74000.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency50.29850.000714.592883.7951AID1259369; AID1259392
thyroid stimulating hormone receptorHomo sapiens (human)Potency5.01190.001318.074339.8107AID926; AID938
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency64.28960.003041.611522,387.1992AID1159552; AID1159553; AID1159555
estrogen nuclear receptor alphaHomo sapiens (human)Potency12.21880.000229.305416,493.5996AID588514; AID743075
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency56.15280.023723.228263.5986AID743222; AID743241
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency57.72070.057821.109761.2679AID1159526; AID1159528
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency58.89940.000323.4451159.6830AID743065
heat shock protein beta-1Homo sapiens (human)Potency57.72070.042027.378961.6448AID743210; AID743228
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency47.30790.000627.21521,122.0200AID651741
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1367493Solubility of the compound2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Improvement in aqueous solubility achieved via small molecular changes.
AID1367487Lipophilicity, log P of the compound2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Improvement in aqueous solubility achieved via small molecular changes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (8.11)18.7374
1990's0 (0.00)18.2507
2000's11 (29.73)29.6817
2010's21 (56.76)24.3611
2020's2 (5.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 55.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index55.17 (24.57)
Research Supply Index3.69 (2.92)
Research Growth Index5.59 (4.65)
Search Engine Demand Index84.57 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (55.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (10.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (89.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]